XOMA Royalty Corp. (XOMA) Financial Ratios
30 years of historical data (1996–2025) · Healthcare · Biotechnology
EV/EBITDA
↑
37.50
↑+64% vs avg
5yr avg: 22.90
30Y Low5.5·High36.7
P/FCF
170.55
+2% vs avg
5yr avg: 166.54
30Y Low16.6·High166.5
P/B Ratio
↑
8.85
↑+189% vs avg
5yr avg: 3.07
30Y Low1.7·High133.6
ROE
↑
38.2%
↓+1344% vs avg
5yr avg: -3.1%
30Y Low-390%·High252%
Debt/EBITDA
↑
9.16
↑+100% vs avg
5yr avg: 4.59
30Y Low0.0·High12.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
XOMA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
XOMA Royalty Corp. trades at 28.3x earnings, 12% above its 5-year average of 25.1x, sitting at the 20th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a premium of 27%. On a free-cash-flow basis, the stock trades at 170.6x P/FCF, roughly in line with the 5-year average of 166.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $490M | $478M | $308M | $212M | $210M | $254M | $508M | $239M | $106M | $284M | $25M |
| Enterprise Value | $538M | $527M | $325M | $183M | $152M | $161M | $445M | $215M | $83M | $255M | $43M |
| P/E Ratio → | 28.28 | 18.21 | — | — | — | 32.08 | 56.58 | — | — | 48.77 | — |
| P/S Ratio | 9.39 | 9.17 | 10.79 | 44.60 | 34.84 | 6.66 | 17.28 | 13.02 | 19.99 | 5.39 | 4.57 |
| P/B Ratio | 8.85 | 5.70 | 3.75 | 2.39 | 1.69 | 1.79 | 5.87 | 5.44 | 5.64 | 49.10 | — |
| P/FCF | 170.55 | 166.54 | — | — | — | — | 57.15 | — | — | 106.08 | — |
| P/OCF | 170.55 | 166.54 | — | — | — | 11.21 | 50.30 | — | — | 105.77 | — |
P/E links to full P/E history page with 30-year chart
XOMA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
XOMA Royalty Corp.'s enterprise value stands at 37.5x EBITDA, 64% above its 5-year average of 22.9x. The Healthcare sector median is 14.4x, placing the stock at a 161% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 10.10 | 11.41 | 38.54 | 25.25 | 4.22 | 15.13 | 11.73 | 15.59 | 4.84 | 7.70 |
| EV / EBITDA | 37.50 | 36.69 | — | — | — | 9.10 | 35.32 | — | — | 14.72 | — |
| EV / EBIT | 47.29 | 46.27 | — | — | — | 9.85 | 32.60 | — | — | 14.59 | — |
| EV / FCF | — | 183.49 | — | — | — | — | 50.06 | — | — | 95.29 | — |
XOMA Profitability
Margins and return-on-capital ratios measuring operating efficiency
XOMA Royalty Corp. earns an operating margin of 21.8%. Operating margins have expanded from -879.5% to 21.8% over the past 3 years, signaling improving operational efficiency. Return on equity of 38.2% is exceptionally high. ROIC of 7.4% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 94.3% | 94.3% | 99.3% | 97.0% | 95.5% | 99.6% | 99.4% | 93.2% | 68.3% | 85.1% | 74.8% |
| Operating Margin | 21.8% | 21.8% | -140.3% | -879.5% | -288.9% | 45.9% | 42.3% | -21.1% | -318.1% | 32.3% | -1106.4% |
| Net Profit Margin | 60.8% | 60.8% | -48.5% | -858.2% | -283.8% | 41.4% | 45.3% | -10.8% | -251.8% | 27.7% | -962.1% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 38.2% | 38.2% | -16.2% | -38.4% | -12.9% | 13.8% | 20.4% | -6.3% | -108.6% | 252.3% | — |
| ROA | 12.8% | 12.8% | -6.1% | -21.8% | -11.1% | 10.8% | 12.0% | -2.5% | -24.5% | 39.7% | -103.4% |
| ROIC | 7.4% | 7.4% | -37.6% | -49.8% | -22.7% | 36.4% | 42.7% | -37.3% | — | — | — |
| ROCE | 5.2% | 5.2% | -19.4% | -24.0% | -12.1% | 13.2% | 12.4% | -5.4% | -35.3% | 101.1% | -257.8% |
XOMA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
XOMA Royalty Corp. carries a Debt/EBITDA ratio of 9.2x, which is highly leveraged (179% above the sector average of 3.3x). Net debt stands at $49M ($132M total debt minus $83M cash). Interest coverage of just 0.9x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.57 | 1.57 | 1.46 | 1.40 | 0.00 | 0.00 | 0.25 | 0.75 | 1.20 | 2.52 | — |
| Debt / EBITDA | 9.16 | 9.16 | — | — | — | 0.01 | 1.69 | — | — | 0.84 | — |
| Net Debt / Equity | — | 0.58 | 0.21 | -0.33 | -0.47 | -0.66 | -0.73 | -0.54 | -1.24 | -4.99 | — |
| Net Debt / EBITDA | 3.39 | 3.39 | — | — | — | -5.26 | -5.00 | — | — | -1.67 | — |
| Debt / FCF | — | 16.94 | — | — | — | — | -7.09 | — | — | -10.79 | — |
| Interest Coverage | 0.87 | 0.87 | -2.89 | -73.55 | — | 38.02 | 6.73 | -2.02 | -18.28 | 13.76 | -15.60 |
XOMA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
XOMA Royalty Corp.'s current ratio of 3.37x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 8.68x to 3.37x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.37 | 3.37 | 5.15 | 8.68 | 8.98 | 7.48 | 7.16 | 6.76 | 8.35 | 5.95 | 0.84 |
| Quick Ratio | 3.37 | 3.37 | 5.15 | 8.68 | 8.98 | 7.48 | 7.03 | 6.76 | 8.35 | 5.95 | 0.84 |
| Cash Ratio | 2.39 | 2.39 | 4.32 | 7.87 | 8.53 | 7.26 | 6.85 | 6.39 | 8.03 | 5.86 | 0.79 |
| Asset Turnover | — | 0.19 | 0.13 | 0.02 | 0.04 | 0.23 | 0.23 | 0.19 | 0.08 | 1.17 | 0.19 |
| Inventory Turnover | — | — | — | — | — | — | 0.11 | — | — | — | — |
| Days Sales Outstanding | — | 34.27 | 218.01 | 1167.49 | 143.35 | 2.00 | 22.22 | 58.28 | 101.12 | 2.75 | 37.13 |
XOMA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
XOMA Royalty Corp. returns 4.0% to shareholders annually — split between a 0.7% dividend yield and 3.3% buyback yield. The earnings yield of 3.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.7% | 1.1% | 1.8% | 2.6% | 2.6% | 1.4% | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.5% | 5.5% | — | — | — | 3.1% | 1.8% | — | — | 2.1% | — |
| FCF Yield | 0.6% | 0.6% | — | — | — | — | 1.7% | — | — | 0.9% | — |
| Buyback Yield | 3.3% | 3.4% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 4.0% | 4.5% | 1.8% | 2.6% | 2.6% | 1.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $18M | $12M | $11M | $11M | $12M | $12M | $9M | $8M | $8M | $6M |
Peer Comparison
Compare XOMA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 XOMAYou | $490M | 28.3 | 37.5 | 170.6 | 94.3% | 21.8% | 38.2% | 7.4% | 9.2 |
 RPRX | $22B | 27.9 | 19.1 | 8.6 | 100.0% | 65.6% | 7.7% | 6.7% | 5.7 |
 BCYC | $339M | -1.5 | — | — | 100.0% | -341.3% | -31.2% | — | — |
 OMAB | $5B | 16.7 | 10.2 | 12.1 | 75.6% | 56.0% | 48.6% | 31.7% | 1.4 |
 RCUS | $2B | -7.5 | — | — | 96.0% | -156.3% | -63.3% | -64.1% | — |
 NUVL | $8B | -17.5 | — | — | — | — | -36.7% | -32.5% | — |
 PRAX | $10B | -24.7 | — | — | — | — | -45.8% | -65.0% | — |
 PFE | $151B | 19.5 | 10.7 | 16.6 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 MRK | $277B | 15.4 | 10.7 | 22.4 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 |
 ABBV | $358B | 85.5 | 15.0 | 20.1 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
 BMY | $115B | 16.3 | 9.2 | 8.9 | 67.6% | 26.3% | 40.4% | 16.9% | 2.8 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
See XOMA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XOMA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XOMA vs RPRX
Side-by-side business, growth, and profitability comparison vs Royalty Pharma plc.
Start ComparisonXOMA — Frequently Asked Questions
Quick answers to the most common questions about buying XOMA stock.
What is XOMA Royalty Corp.'s P/E ratio?
XOMA Royalty Corp.'s current P/E ratio is 28.3x. The historical average is 41.8x. This places it at the 20th percentile of its historical range.
What is XOMA Royalty Corp.'s EV/EBITDA?
XOMA Royalty Corp.'s current EV/EBITDA is 37.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 20.3x.
What is XOMA Royalty Corp.'s ROE?
XOMA Royalty Corp.'s return on equity (ROE) is 38.2%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is -88.8%.
Is XOMA stock overvalued?
Based on historical data, XOMA Royalty Corp. is trading at a P/E of 28.3x. This is at the 20th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is XOMA Royalty Corp.'s dividend yield?
XOMA Royalty Corp.'s current dividend yield is 0.74%.
What are XOMA Royalty Corp.'s profit margins?
XOMA Royalty Corp. has 94.3% gross margin and 21.8% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does XOMA Royalty Corp. have?
XOMA Royalty Corp.'s Debt/EBITDA ratio is 9.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.